TERN Terns Pharmaceuticals, Inc.
Healthcare$52.95-0.03%ClosedMarket Cap: $4.77B
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$55.56
Target (Median)
$56.00
Target Range
$35.00 - $70.00
Upside from current price: 4.9%
Rating Distribution
0 Strong Buy0 Buy10 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-27 | Oppenheimer | downgrade | Perform | Outperform |
| 2026-04-14 | JP Morgan | maintain | Overweight | Overweight |
| 2026-03-31 | Truist Securities | downgrade | Hold | Buy |
| 2026-03-30 | Barclays | downgrade | Equal Weight | Overweight |
| 2026-03-26 | Citizens | downgrade | Market Perform | Market Outperform |
| 2026-03-26 | TD Cowen | downgrade | Hold | Buy |
| 2026-03-25 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2025-12-11 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-12-09 | Barclays | maintain | Overweight | Overweight |
| 2025-12-09 | Mizuho | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-1.16 | $960.0K | 4 |
| Fri Dec 31 | $-1.43 | $5.8M | 4 |
| Sun Dec 31 | $-1.81 | $11.8M | 4 |
| Mon Dec 31 | $-1.51 | $60.1M | 2 |